J M Fleming

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines
    Matthew J Meyer
    Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Building 37, Room 1106, Bethesda, Maryland 20892 4254, USA
    Breast Cancer Res 11:R82. 2009
  2. pmc The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo
    Jodie M Fleming
    Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
    BMC Med 8:27. 2010
  3. pmc Interlobular and intralobular mammary stroma: genotype may not reflect phenotype
    J M Fleming
    Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    BMC Cell Biol 9:46. 2008
  4. pmc Characterization of Δ7/11, a functional prolactin-binding protein
    J M Fleming
    Mammary Biology and Tumorigenesis Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Mol Endocrinol 50:79-90. 2013
  5. pmc 16 kDa prolactin reduces angiogenesis, but not growth of human breast cancer tumors in vivo
    J M Faupel-Badger
    Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA
    Horm Cancer 1:71-9. 2010
  6. ncbi request reprint IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells
    J M Fleming
    Department of Animal Sciences, Rutgers The State University of New Jersey, 108 Foran Hall, 59 Dudley Road, New Brunswick, New Jersey 08901 8520, USA
    J Endocrinol 186:165-78. 2005

Collaborators

Detail Information

Publications6

  1. pmc Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines
    Matthew J Meyer
    Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Building 37, Room 1106, Bethesda, Maryland 20892 4254, USA
    Breast Cancer Res 11:R82. 2009
    ..This interconversion was found to be dependent upon Activin/Nodal signaling...
  2. pmc The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo
    Jodie M Fleming
    Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
    BMC Med 8:27. 2010
    ..We chose these two populations because of the well documented predisposition of AA women to develop aggressive, highly metastatic breast cancer compared to CAU women...
  3. pmc Interlobular and intralobular mammary stroma: genotype may not reflect phenotype
    J M Fleming
    Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    BMC Cell Biol 9:46. 2008
    ..The different proximity of these fibroblasts to the epithelial cells suggests distinctive functions for these two subtypes. In this report, we compared the gene expression profiles between the two stromal subtypes...
  4. pmc Characterization of Δ7/11, a functional prolactin-binding protein
    J M Fleming
    Mammary Biology and Tumorigenesis Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Mol Endocrinol 50:79-90. 2013
    ..Collectively, these data demonstrate that Δ7/11 is a novel regulatory mechanism of prolactin bioavailability and signaling...
  5. pmc 16 kDa prolactin reduces angiogenesis, but not growth of human breast cancer tumors in vivo
    J M Faupel-Badger
    Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA
    Horm Cancer 1:71-9. 2010
    ..g. local hormone/mitogen concentration) may play a dominant role in tumor formation in vivo, thus outweighing the anti-angiogenesis effects and in vitro reduction in cell proliferation induced by 16 kDa PRL...
  6. ncbi request reprint IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells
    J M Fleming
    Department of Animal Sciences, Rutgers The State University of New Jersey, 108 Foran Hall, 59 Dudley Road, New Brunswick, New Jersey 08901 8520, USA
    J Endocrinol 186:165-78. 2005
    ....